| |
|
|
|
Conference Programme
|
Tuesday 20 October 09
|
|
11-30-12.30
|
Registration and Welcome lunch
|
| Room: Attic 1&2 |
| |
Plenary Introduction
|
| |
|
12-30-12.40
|
Dr.P.Stas, Chairman Bio.be, Belgian Association for Bio Industries, CEO Algonomics
|
| |
| |
Plenary Session
|
| |
|
12.40-13.10
|
“Networks in Drug Discovery: a description on how integrated analysis in a network context could help to identify new intervention points, biomarkers or new disease indications”
Dr.Matthew Hall, UK Team Leader, Computational Biology
GSK Pharma, Stevenage, UK
|
|
13.10-13.40
|
“Innovation from the lab to the computer room at Danone research”
Dr.Jean-Luc Tonneau, Strategic Planning Director
Danone, Paris, F
|
|
13-40-14.10
|
“Through a collaboration with the Friedrich Miescher Institute (Novartis Research Foundation) Life Sciences Framework (LSF) provides a metadata-driven, standards-based infrastructure for life science research”
Dr.John Smit, CEO
Metainformatics,
Austin, Texas, US
|
|
14.10-14.40
|
“How to maximize synergies between experimental and integrative biology. In-vivo validation of CADI models in Creutzfeldt-Jakob, mad cow disease”
Bio-IT World 2009 Best Practice Award
Dr.Frank Mouthon, CEA, Fontenay aux Roses, F.
Dr.François Iris, CSO, Bio-Modeling Systems, Paris, F.
|
| |
|
14.40-15.10
|
Coffee break
|
| |
| |
Plenary Session
|
|
15.10-15.40
|
“Metabolite profiling: opening new dimensions in biomarker research”
Dr.Mathieu Klein, Technical Center Leader Bioinformatics
Metanomics, BASF,Berlin, D
|
|
15.40-16.10
|
“Computational modeling of cardiac disease: potential for personalized medicine”
Dr.Matthias Reumann, Functional Genomics and Systems Biology, Computational Biology Center
IBM, T.J.Watson Research Center, Yorktown Heights, NY, US
|
|
16.10-16.40
|
“Taming Structures and Reactions”
Pr.Dr.Jonathan Goodman
Group Leader, Dpt of Chemistry, Cambridge University
Unilever Centre for Molecular Sciences Informatics, UK
|
|
16.40-17.10
|
“Applying text-analytics and knowledge mapping to support drug discovery”
Dr.Luca Toldo, Principal Research Scientist, Knowledge Management
Merck KGaA, Darmstadt, D
|
| |
| |
Exhibitors speech / Case study
|
|
17.10-17.20
|
DNAVision, Gosselies, B
|
|
17.20-17.30
|
Temis, Paris, F
|
|
17.30-17.40
|
Aureus Pharma, Paris, F
|
|
17.40-17.50
|
BioXpr, Namur, B “The BioXplain Initiative”
|
| |
|
17.40-19.00
|
Reception Drink
|
|
Wednesday 21 October 09
|
|
08.30-09.00
|
Registration
|
| |
| |
Pharma and Red Biotech Track
|
Green, White,…Biotech track
|
| |
Room: Attic 1&2
|
Room: Convention 1
|
|
09.00-09.30
|
“Improving antibody properties by semi-rational in-silico engineering: a realistic perspective”
Dr.Philippe Alard, Head of Bioinformatics,
Algonomics, Ghent, B
|
“Applied bioinformatics in a leading plant breeding company”
Dr.Andreas Menze, R&D Information Management/Bioinformatics
KWS Saat,
Einbeck, D
|
|
09.30-10.00
|
“Enabling Interactive Multi-Objective Optimization for Drug Discovery Scientists”
Dr.Ed Champness, CSO
Optibrium, Cambridge, UK
|
“Next Generation Sequencing Technologies in Plant Genomes : status and challenges”
Dr.Laurent Viau, BioAnalysis Services Team Leader, Bioinformation Dpt.
Bayer Crop Sciences, Ghent, B
|
|
10.00-10.30
|
“Computational Drug Repositioning: a description of the challenges and promises of computational approaches in drug repositioning with examples”
Dr.Matthew Hall, UK Team Leader, Computational Biology
GSK Pharma, Stevenage, UK
|
“Improving T4 phage knowledge using HTS and comparative genomics”
Dr.Catherine Ngom-Bru, Bioinformatician
Nestlé,Lausanne, CH
|
| |
|
10.30-11.00
|
Coffee Break
|
| |
|
11.00-11.30
|
“Transcript Profiling for Epithelial-Mesenchymal Transition (EMT): Signature identification and validation”
Dr.An de Bondt, Senior Scientist
J&J Pharmaceuticals R&D,
Beerse, B
|
“Profiling microbial communities using Next Gen Sequencing: a validation study on human GI-tract samples”
Dr.Lutz Krause, Bioinformatics Research Scientist, Functional Genomics Group, BioAnalytical Science Dpt.
Nestlé,Lausanne, CH
|
|
11.30-12.00
|
“NeuroSpin, Managing Neuroimaging and genetic databases for predicting risk factors”
Dr.Jean-Baptiste Poline, Chargé de Recherche
CEA, Saclay, F
|
“Systems biology of lignification and relevance to biofuels”
Dr.Wout Boerjan, Group Leader, Bio-Energy, Plant Systems Biology,
VIB, Ghent, B
|
| |
| |
Plenary Session
|
Room: Attic 1&2
|
|
12.00-12.40
|
“A gaze into the crystal ball: What will Future Pharma R&D look like?”
Dr.Thomas Senderovitz, VP, Global Exploratory Medicine,
UCB Pharma, Braine-L'Alleud, B
|
|
12.40-13.20
|
“Patient Centered drug discovery: A translational medicine model integrating systems biology approaches”
Dr.Antoine Bril, Research Associate Director
Servier, Suresnes, F
|
| |
|
13.20-13.30
|
Conference Closing Session
|
| |
|
13.30-14.30
|
Closing drink
|
|
|
|
|
|
|
